Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Health behavior among working adults: Workload and exhaustion are associated with nutrition and physical activity behaviors that lead to weight gain.

Padilla HM, Wilson M, Vandenberg RJ, Davis M, Clark MA.

J Health Psychol. 2019 May 30:1359105319851205. doi: 10.1177/1359105319851205. [Epub ahead of print]

PMID:
31144527
2.

The workplace health group: A case study of 20 years of multidisciplinary research.

Haynes NJ, Vandenberg RJ, DeJoy DM, Wilson MG, Padilla HM, Zuercher HS, Robertson MM.

Am Psychol. 2019 Apr;74(3):380-393. doi: 10.1037/amp0000445.

PMID:
30945899
3.

Development of an N-Acyl Amino Acid That Selectively Inhibits the Glycine Transporter 2 To Produce Analgesia in a Rat Model of Chronic Pain.

Mostyn SN, Rawling T, Mohammadi S, Shimmon S, Frangos ZJ, Sarker S, Yousuf A, Vetter I, Ryan RM, Christie MJ, Vandenberg RJ.

J Med Chem. 2019 Mar 14;62(5):2466-2484. doi: 10.1021/acs.jmedchem.8b01775. Epub 2019 Feb 20.

4.

Cost Effectiveness of a Weight Management Program Implemented in the Worksite: Translation of Fuel Your Life.

Corso PS, Ingels JB, Padilla HM, Zuercher H, DeJoy DM, Vandenberg RJ, Wilson MG.

J Occup Environ Med. 2018 Aug;60(8):683-687. doi: 10.1097/JOM.0000000000001343.

5.

Does Organizational and Coworker Support Moderate Diabetes Risk and Job Stress Among Employees?

Wolff MB, Gay JL, Wilson MG, DeJoy DM, Vandenberg RJ.

Am J Health Promot. 2018 May;32(4):959-962. doi: 10.1177/0890117116685802. Epub 2016 Dec 29.

PMID:
29667501
6.

Activity of novel lipid glycine transporter inhibitors on synaptic signalling in the dorsal horn of the spinal cord.

Winters BL, Rawling T, Vandenberg RJ, Christie MJ, Bhola RF, Imlach WL.

Br J Pharmacol. 2018 Jun;175(12):2337-2347. doi: 10.1111/bph.14189. Epub 2018 Apr 14.

7.

Structural characterisation reveals insights into substrate recognition by the glutamine transporter ASCT2/SLC1A5.

Scopelliti AJ, Font J, Vandenberg RJ, Boudker O, Ryan RM.

Nat Commun. 2018 Jan 2;9(1):38. doi: 10.1038/s41467-017-02444-w.

8.

Molecular Determinants for Substrate Interactions with the Glycine Transporter GlyT2.

Carland JE, Thomas M, Mostyn SN, Subramanian N, O'Mara ML, Ryan RM, Vandenberg RJ.

ACS Chem Neurosci. 2018 Mar 21;9(3):603-614. doi: 10.1021/acschemneuro.7b00407. Epub 2017 Nov 27.

PMID:
29120604
9.

Synthesis and Characterization of Novel Acyl-Glycine Inhibitors of GlyT2.

Mostyn SN, Carland JE, Shimmon S, Ryan RM, Rawling T, Vandenberg RJ.

ACS Chem Neurosci. 2017 Sep 20;8(9):1949-1959. doi: 10.1021/acschemneuro.7b00105. Epub 2017 Jun 15.

PMID:
28574249
10.

The amino acid transporter, SLC1A3, is plasma membrane-localised in adipocytes and its activity is insensitive to insulin.

Krycer JR, Fazakerley DJ, Cater RJ, C Thomas K, Naghiloo S, Burchfield JG, Humphrey SJ, Vandenberg RJ, Ryan RM, James DE.

FEBS Lett. 2017 Jan;591(2):322-330. doi: 10.1002/1873-3468.12549. Epub 2017 Jan 13.

11.

Characterization of the Inward- and Outward-Facing Substrate Binding Sites of the Prokaryotic Aspartate Transporter, GltPh.

McIlwain BC, Vandenberg RJ, Ryan RM.

Biochemistry. 2016 Dec 13;55(49):6801-6810. Epub 2016 Dec 2.

PMID:
27951659
12.

Effect of Intensity and Program Delivery on the Translation of Diabetes Prevention Program to Worksites: A Randomized Controlled Trial of Fuel Your Life.

Wilson MG, DeJoy DM, Vandenberg RJ, Corso P, Padilla H, Zuercher H.

J Occup Environ Med. 2016 Nov;58(11):1113-1120.

13.

A Prospective Programmatic Cost Analysis of Fuel Your Life: A Worksite Translation of DPP.

Ingels JB, Walcott RL, Wilson MG, Corso PS, Padilla HM, Zuercher H, DeJoy DM, Vandenberg RJ.

J Occup Environ Med. 2016 Nov;58(11):1106-1112.

14.

Brain transporters: From genes and genetic disorders to function and drug discovery.

Vandenberg RJ, Ryan R, Broer S.

Neurochem Int. 2016 Sep;98:1-3. doi: 10.1016/j.neuint.2016.07.005. No abstract available.

PMID:
27475459
15.

Correction: Identification of a 3rd Na+ Binding Site of the Glycine Transporter, GlyT2.

Subramanian N, Scopelliti AJ, Carland JE, Ryan RM, O'Mara ML, Vandenberg RJ.

PLoS One. 2016 Jul 19;11(7):e0159896. doi: 10.1371/journal.pone.0159896. eCollection 2016.

16.

Identification of a 3rd Na+ Binding Site of the Glycine Transporter, GlyT2.

Subramanian N, Scopelitti AJ, Carland JE, Ryan RM, O'Mara ML, Vandenberg RJ.

PLoS One. 2016 Jun 23;11(6):e0157583. doi: 10.1371/journal.pone.0157583. eCollection 2016. Erratum in: PLoS One. 2016;11(7):e0159896.

17.

Tuning the ion selectivity of glutamate transporter-associated uncoupled conductances.

Cater RJ, Vandenberg RJ, Ryan RM.

J Gen Physiol. 2016 Jul;148(1):13-24. doi: 10.1085/jgp.201511556. Epub 2016 Jun 13.

18.

Enhanced Co-Worker Social Support in Isolated Work Groups and Its Mitigating Role on the Work-Family Conflict-Depression Loss Spiral.

McTernan WP, Dollard MF, Tuckey MR, Vandenberg RJ.

Int J Environ Res Public Health. 2016 Mar 29;13(4):382. doi: 10.3390/ijerph13040382.

19.

Elevating the alternating-access model.

Ryan RM, Vandenberg RJ.

Nat Struct Mol Biol. 2016 Mar;23(3):187-9. doi: 10.1038/nsmb.3179. No abstract available.

PMID:
26931415
20.

Glycine transporter2 inhibitors: Getting the balance right.

Vandenberg RJ, Mostyn SN, Carland JE, Ryan RM.

Neurochem Int. 2016 Sep;98:89-93. doi: 10.1016/j.neuint.2015.12.007. Epub 2015 Dec 23.

PMID:
26723543
21.

The Split Personality of Glutamate Transporters: A Chloride Channel and a Transporter.

Cater RJ, Ryan RM, Vandenberg RJ.

Neurochem Res. 2016 Mar;41(3):593-9. doi: 10.1007/s11064-015-1699-6. Epub 2015 Aug 25.

PMID:
26303507
22.

Transport rates of a glutamate transporter homologue are influenced by the lipid bilayer.

McIlwain BC, Vandenberg RJ, Ryan RM.

J Biol Chem. 2015 Apr 10;290(15):9780-8. doi: 10.1074/jbc.M114.630590. Epub 2015 Feb 20.

23.

The domain interface of the human glutamate transporter EAAT1 mediates chloride permeation.

Cater RJ, Vandenberg RJ, Ryan RM.

Biophys J. 2014 Aug 5;107(3):621-629. doi: 10.1016/j.bpj.2014.05.046.

24.

Glycine transport inhibitors for the treatment of pain.

Vandenberg RJ, Ryan RM, Carland JE, Imlach WL, Christie MJ.

Trends Pharmacol Sci. 2014 Aug;35(8):423-30. doi: 10.1016/j.tips.2014.05.006. Epub 2014 Jun 21. Review.

PMID:
24962068
25.

Applying RE-AIM to the evaluation of FUEL Your Life : a worksite translation of DPP.

Brace AM, Padilla HM, DeJoy DM, Wilson MG, Vandenberg RJ, Davis M.

Health Promot Pract. 2015 Jan;16(1):28-35. doi: 10.1177/1524839914539329. Epub 2014 Jun 18.

PMID:
24942749
26.

Na+ interactions with the neutral amino acid transporter ASCT1.

Scopelliti AJ, Heinzelmann G, Kuyucak S, Ryan RM, Vandenberg RJ.

J Biol Chem. 2014 Jun 20;289(25):17468-79. doi: 10.1074/jbc.M114.565242. Epub 2014 May 7.

27.

Developmental Climate: A Cross-level Analysis of Voluntary Turnover and Job Performance.

Spell HB, Eby LT, Vandenberg RJ.

J Vocat Behav. 2014 Jun 1;84(3):283-292.

28.

The Concise Guide to PHARMACOLOGY 2013/14: overview.

Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, McGrath JC, Catterall WA, Spedding M, Peters JA, Harmar AJ; CGTP Collaborators, Abul-Hasn N, Anderson CM, Anderson CM, Araiksinen MS, Arita M, Arthofer E, Barker EL, Barratt C, Barnes NM, Bathgate R, Beart PM, Belelli D, Bennett AJ, Birdsall NJ, Boison D, Bonner TI, Brailsford L, Bröer S, Brown P, Calo G, Carter WG, Catterall WA, Chan SL, Chao MV, Chiang N, Christopoulos A, Chun JJ, Cidlowski J, Clapham DE, Cockcroft S, Connor MA, Cox HM, Cuthbert A, Dautzenberg FM, Davenport AP, Dawson PA, Dent G, Dijksterhuis JP, Dollery CT, Dolphin AC, Donowitz M, Dubocovich ML, Eiden L, Eidne K, Evans BA, Fabbro D, Fahlke C, Farndale R, Fitzgerald GA, Fong TM, Fowler CJ, Fry JR, Funk CD, Futerman AH, Ganapathy V, Gaisnier B, Gershengorn MA, Goldin A, Goldman ID, Gundlach AL, Hagenbuch B, Hales TG, Hammond JR, Hamon M, Hancox JC, Hauger RL, Hay DL, Hobbs AJ, Hollenberg MD, Holliday ND, Hoyer D, Hynes NA, Inui KI, Ishii S, Jacobson KA, Jarvis GE, Jarvis MF, Jensen R, Jones CE, Jones RL, Kaibuchi K, Kanai Y, Kennedy C, Kerr ID, Khan AA, Klienz MJ, Kukkonen JP, Lapoint JY, Leurs R, Lingueglia E, Lippiat J, Lolait SJ, Lummis SC, Lynch JW, MacEwan D, Maguire JJ, Marshall IL, May JM, McArdle CA, McGrath JC, Michel MC, Millar NS, Miller LJ, Mitolo V, Monk PN, Moore PK, Moorhouse AJ, Mouillac B, Murphy PM, Neubig RR, Neumaier J, Niesler B, Obaidat A, Offermanns S, Ohlstein E, Panaro MA, Parsons S, Pwrtwee RG, Petersen J, Pin JP, Poyner DR, Prigent S, Prossnitz ER, Pyne NJ, Pyne S, Quigley JG, Ramachandran R, Richelson EL, Roberts RE, Roskoski R, Ross RA, Roth M, Rudnick G, Ryan RM, Said SI, Schild L, Sanger GJ, Scholich K, Schousboe A, Schulte G, Schulz S, Serhan CN, Sexton PM, Sibley DR, Siegel JM, Singh G, Sitsapesan R, Smart TG, Smith DM, Soga T, Stahl A, Stewart G, Stoddart LA, Summers RJ, Thorens B, Thwaites DT, Toll L, Traynor JR, Usdin TB, Vandenberg RJ, Villalon C, Vore M, Waldman SA, Ward DT, Willars GB, Wonnacott SJ, Wright E, Ye RD, Yonezawa A, Zimmermann M.

Br J Pharmacol. 2013 Dec;170(8):1449-58. doi: 10.1111/bph.12444.

29.

Mechanisms of glutamate transport.

Vandenberg RJ, Ryan RM.

Physiol Rev. 2013 Oct;93(4):1621-57. doi: 10.1152/physrev.00007.2013. Review.

30.

Lipid inhibitors of high affinity glycine transporters: identification of a novel class of analgesics.

Carland JE, Handford CA, Ryan RM, Vandenberg RJ.

Neurochem Int. 2014 Jul;73:211-6. doi: 10.1016/j.neuint.2013.08.012. Epub 2013 Sep 12. Review.

PMID:
24036283
31.

Molecular determinants for functional differences between alanine-serine-cysteine transporter 1 and other glutamate transporter family members.

Scopelliti AJ, Ryan RM, Vandenberg RJ.

J Biol Chem. 2013 Mar 22;288(12):8250-7. doi: 10.1074/jbc.M112.441022. Epub 2013 Feb 7.

32.

Worksite translation of the Diabetes Prevention Program: formative research and pilot study results from FUEL Your Life.

DeJoy DM, Padilla HM, Wilson MG, Vandenberg RJ, Davis MA.

Health Promot Pract. 2013 Jul;14(4):506-13. doi: 10.1177/1524839912461014. Epub 2012 Oct 22.

PMID:
23091301
33.

Oleoyl-L-carnitine inhibits glycine transport by GlyT2.

Carland JE, Mansfield RE, Ryan RM, Vandenberg RJ.

Br J Pharmacol. 2013 Feb;168(4):891-902. doi: 10.1111/j.1476-5381.2012.02213.x.

34.

Position of the third Na+ site in the aspartate transporter GltPh and the human glutamate transporter, EAAT1.

Bastug T, Heinzelmann G, Kuyucak S, Salim M, Vandenberg RJ, Ryan RM.

PLoS One. 2012;7(3):e33058. doi: 10.1371/journal.pone.0033058. Epub 2012 Mar 13.

35.

Water and urea permeation pathways of the human excitatory amino acid transporter EAAT1.

Vandenberg RJ, Handford CA, Campbell EM, Ryan RM, Yool AJ.

Biochem J. 2011 Oct 15;439(2):333-40. doi: 10.1042/BJ20110905.

PMID:
21732909
36.

Loss-of-function mutations in the glutamate transporter SLC1A1 cause human dicarboxylic aminoaciduria.

Bailey CG, Ryan RM, Thoeng AD, Ng C, King K, Vanslambrouck JM, Auray-Blais C, Vandenberg RJ, Bröer S, Rasko JE.

J Clin Invest. 2011 Jan;121(1):446-53. doi: 10.1172/JCI44474. Epub 2010 Dec 1.

37.

N-arachidonyl-glycine modulates synaptic transmission in superficial dorsal horn.

Jeong HJ, Vandenberg RJ, Vaughan CW.

Br J Pharmacol. 2010 Oct;161(4):925-35. doi: 10.1111/j.1476-5381.2010.00935.x.

38.

Exon-skipping splice variants of excitatory amino acid transporter-2 (EAAT2) form heteromeric complexes with full-length EAAT2.

Gebhardt FM, Mitrovic AD, Gilbert DF, Vandenberg RJ, Lynch JW, Dodd PR.

J Biol Chem. 2010 Oct 8;285(41):31313-24. doi: 10.1074/jbc.M110.153494. Epub 2010 Aug 5.

39.

N-acyl amino acids and N-acyl neurotransmitter conjugates: neuromodulators and probes for new drug targets.

Connor M, Vaughan CW, Vandenberg RJ.

Br J Pharmacol. 2010 Aug;160(8):1857-71. doi: 10.1111/j.1476-5381.2010.00862.x. Review.

40.

Using constructs of the transtheoretical model to predict classes of change in regular physical activity: a multi-ethnic longitudinal cohort study.

Dishman RK, Vandenberg RJ, Motl RW, Nigg CR.

Ann Behav Med. 2010 Oct;40(2):150-63. doi: 10.1007/s12160-010-9196-2.

41.

Making work safer: testing a model of social exchange and safety management.

DeJoy DM, Della LJ, Vandenberg RJ, Wilson MG.

J Safety Res. 2010 Apr;41(2):163-71. doi: 10.1016/j.jsr.2010.02.001. Epub 2010 Mar 10.

PMID:
20497802
42.

The position of an arginine residue influences substrate affinity and K+ coupling in the human glutamate transporter, EAAT1.

Ryan RM, Kortt NC, Sirivanta T, Vandenberg RJ.

J Neurochem. 2010 Jul;114(2):565-75. doi: 10.1111/j.1471-4159.2010.06796.x. Epub 2010 May 6.

43.

Site-directed mutagenesis in the study of membrane transporters.

McKinzie AA, Ryan RM, Vandenberg RJ.

Methods Mol Biol. 2010;637:277-93. doi: 10.1007/978-1-60761-700-6_15.

PMID:
20419441
44.

Glutamate transporter variants reduce glutamate uptake in Alzheimer's disease.

Scott HA, Gebhardt FM, Mitrovic AD, Vandenberg RJ, Dodd PR.

Neurobiol Aging. 2011 Mar;32(3):553.e1-11. doi: 10.1016/j.neurobiolaging.2010.03.008. Epub 2010 Apr 22.

PMID:
20416976
45.

Extracellular loops 2 and 4 of GLYT2 are required for N-arachidonylglycine inhibition of glycine transport.

Edington AR, McKinzie AA, Reynolds AJ, Kassiou M, Ryan RM, Vandenberg RJ.

J Biol Chem. 2009 Dec 25;284(52):36424-30. doi: 10.1074/jbc.M109.017509. Epub 2009 Oct 29.

46.

Association of comorbid mental health symptoms and physical health conditions with employee productivity.

Parker KM, Wilson MG, Vandenberg RJ, DeJoy DM, Orpinas P.

J Occup Environ Med. 2009 Oct;51(10):1137-44. doi: 10.1097/JOM.0b013e3181b8c155.

PMID:
19786901
47.

Dose relations between goal setting, theory-based correlates of goal setting and increases in physical activity during a workplace trial.

Dishman RK, Vandenberg RJ, Motl RW, Wilson MG, DeJoy DM.

Health Educ Res. 2010 Aug;25(4):620-31. doi: 10.1093/her/cyp042. Epub 2009 Aug 4.

PMID:
19654220
48.

Exploring relationships among anger, perceived organizational support, and workplace outcomes.

O'Neill OA, Vandenberg RJ, Dejoy DM, Wilson MG.

J Occup Health Psychol. 2009 Jul;14(3):318-33. doi: 10.1037/a0015852.

PMID:
19586225
49.

Social-cognitive correlates of physical activity in a multi-ethnic cohort of middle-school girls: two-year prospective study.

Dishman RK, Dunn AL, Sallis JF, Vandenberg RJ, Pratt CA.

J Pediatr Psychol. 2010 Mar;35(2):188-98. doi: 10.1093/jpepsy/jsp042. Epub 2009 May 25.

50.

Modulation of glutamate and glycine transporters by niflumic, flufenamic and mefenamic acids.

Habjan S, Vandenberg RJ.

Neurochem Res. 2009 Oct;34(10):1738-47. doi: 10.1007/s11064-009-9983-y. Epub 2009 May 15.

PMID:
19444608

Supplemental Content

Loading ...
Support Center